1-7 of 7
Keywords: Chemotherapy
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Subject Area:
Oncology
Tumor Biology (1997) 18 (4): 250–260.
Published Online: 30 April 2009
... management of melanoma. Chemotherapy Radiation Heat-sensitive liposomes Melanoma Melphalan 12 08 1996 17 01 1997 30 4 2009 © 1997 S. Karger AG, Basel 1997 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated...
Journal Articles
Subject Area:
Oncology
Tumor Biology (1992) 13 (5-6): 287–293.
Published Online: 29 April 2009
... to prefixed 95 % specificity values in a group of 674 women with benign gynecologic diseases were taken as cutoff limits (88.8 U/ml for CA 125 and 13.7 U/ml for CAM 29). Moreover, CA 125 and CAM 29 levels were measured serially during and after chemotherapy in 26 women selected from the patients with advanced...
Journal Articles
Journal Articles
Subject Area:
Oncology
Tumor Biology (2004) 25 (5-6): 306–312.
Published Online: 27 December 2004
... cancer CDKN1B Chemotherapy Node involvement p27 Polymorphism Prognosis Research Article Tumor Biol 2004;25:306 312 DOI: 10.1159/000081396 Received: June 27, 2004 Accepted after revision: September 3, 2004 The V109G Polymorphism of the p27 Gene CDKN1B Indicates a Worse Outcome in Node-Negative...
Journal Articles
Journal Articles
Subject Area:
Oncology
Tumor Biology (2003) 24 (1): 32–39.
Published Online: 21 May 2003
... the time-dependent dynamic alterations in the expression of three tumor-associated antigens: carcinoembryonic antigen (CEA), colon-specific antigen (CSAp) and mucin-1 (MUC-1) following chemotherapy with 5-fluorouracil (5-FU) or radioimmunotherapy (RAIT; 131 I-labeled anti-CEA IgG) in human colonic tumor...
Journal Articles
Subject Area:
Oncology
Tumor Biology (2000) 22 (2): 97–103.
Published Online: 15 December 2000
...Thomas Brezicka; Zakaria Einbeigi Chemotherapy with cytostatic and cytotoxic drugs is the main treatment modality for disseminated cancer. However, despite initial clinical responses seen in certain histotypes, such as small cell lung cancer, relapses mostly occur with chemoresistant phenotypes...